SUBSCRIBE
SUBSCRIBE

Mergers & acquisitions

Astellas Pharma, Proteostasis Therapeutics Forge $1.2 Billion Genetic Disease Drug Development Pact
Deals
Rumors Floating Again that Roche or GlaxoSmithKline Might Acquire Bay Area’s Pacific Biosciences
June 3, 2016
 · 
2 min read
Pfizer CEO: What Trump Doesn't Understand About Pharma
Deals
Pfizer Boss Discusses M&A Strategy and Says No to Tax Inversions
June 3, 2016
 · 
2 min read
Here’s Why 5 Billionaire-Led Funds Gobbled Up 3.3 Million Shares of Celldex Stock
Deals
Here’s Why 5 Billionaire-Led Funds Gobbled Up 3.3 Million Shares of Celldex Stock
June 2, 2016
 · 
2 min read
Astellas Pharma, Proteostasis Therapeutics Forge $1.2 Billion Genetic Disease Drug Development Pact
Business
Abbott Tries to Bail Out of $5.8 Billion Deal as Alere Faces Bribery Probes, But it Won’t Be Easy
June 2, 2016
 · 
3 min read
Sanofi Finally Closes a Deal, Pays $750 Million for This Connecticut Biotech
Deals
Why Sanofi is So Infatuated With the Bay Area’s Medivation
June 2, 2016
 · 
3 min read
Deals
Activist Investor Carl Icahn’s Big Buy of Allergan Shares Raises Questions of Influence
June 1, 2016
 · 
3 min read
Astellas Pharma, Proteostasis Therapeutics Forge $1.2 Billion Genetic Disease Drug Development Pact
Deals
Why Intercept Pharma Just Became an Even More Attractive Takeover Target
May 31, 2016
 · 
3 min read
Astellas Pharma, Proteostasis Therapeutics Forge $1.2 Billion Genetic Disease Drug Development Pact
Deals
Jazz Pharma Pays $1.5 Billion for Celator Pharma to Gain a Promising Leukemia Drug
May 31, 2016
 · 
2 min read
Astellas Pharma, Proteostasis Therapeutics Forge $1.2 Billion Genetic Disease Drug Development Pact
Deals
Thermo Fisher Scientific Expands into Pharma Market, Antes Up $4.2 Billion for FEI Company
May 27, 2016
 · 
2 min read
Astellas Pharma, Proteostasis Therapeutics Forge $1.2 Billion Genetic Disease Drug Development Pact
Deals
Embattled Valeant Reportedly Spurned a Takeover Offer from Takeda-TPG
May 27, 2016
 · 
2 min read
Load More
PRESS RELEASES
Deals
Lilly Announces Agreement to Acquire Prevail Therapeutics
December 15, 2020
 · 
11 min read
Deals
Eucrates Biomedical Acquisition Corp. Announces The Separate Trading Of Its Ordinary Shares And Redeemable Warrants
December 14, 2020
 · 
3 min read
Deals
EGF Theramed Signs Agreement to Acquire Seedadelic Med Corp.
December 14, 2020
 · 
2 min read
Deals
Reviva Pharmaceuticals, Inc. and Tenzing Acquisition Corp. Complete their Business Combination and Trade as Reviva Pharmaceuticals Holdings, Inc.
December 14, 2020
 · 
6 min read
Deals
Calibre Scientific Enters the Canadian Market and Expands Product Portfolio With the Acquisition of Canadian Life Science
December 14, 2020
 · 
2 min read
Deals
Eleusis Launches Clinical Development of Psychedelic Infusion Therapies for Major Depressive Disorder and Acquires Kalypso Wellness Centers
December 14, 2020
 · 
3 min read
Deals
CYBIN Closes Acquisition of Adelia Therapeutics; Bolsters Scientific Team and Grows IP Portfolio to 7 Patent Filings
December 14, 2020
 · 
11 min read
Deals
AstraZeneca to Acquire Alexion, Accelerating the Company’s Strategic and Financial Development
December 12, 2020
 · 
32 min read
Deals
PROTEOR Group Becomes One of the Largest Prosthetic Providers in the World
December 11, 2020
 · 
3 min read
Deals
DJO® Acquires LiteCure Laser Therapy
December 11, 2020
 · 
3 min read
Business
Audax Private Debt and Adams Street Partners Provide Financing to Support Freeman Spogli’s Acquisition of US Med-Equip
December 11, 2020
 · 
4 min read
Deals
US Radiology Acquires ImageSouth, Expanding National Radiology Footprint
December 10, 2020
 · 
2 min read
Deals
ERT and Bioclinica to Merge, Creating a Global Leader in Clinical Trial Endpoint Technology
December 10, 2020
 · 
3 min read
Deals
Syneos Health Completes Acquisition of Synteract
December 10, 2020
 · 
5 min read
Deals
Daxor Corporation Announces Further Acquisitions of its BVA-100® Blood Volume Analyzer by Leading Medical Centers Throughout the U.S.
December 10, 2020
 · 
3 min read
Deals
Gilead Sciences to Acquire MYR GmbH
December 10, 2020
 · 
9 min read
Deals
Aytu BioScience and Neos Therapeutics Announce Definitive Merger Agreement, Creating a Combined $100M Revenue(1) Specialty Pharmaceutical Company
December 10, 2020
 · 
14 min read
Deals
Boehringer Ingelheim to Acquire NBE-Therapeutics for EUR 1.18 Billion, Significantly Enhancing Its Cancer Pipeline Portfolio with Novel Antibody-Drug Conjugates
December 10, 2020
 · 
3 min read
Deals
Denovo Biopharma Acquires a Novel Late-Stage Oncology Drug and Expands into Protein Therapeutics
December 10, 2020
 · 
2 min read
Deals
Aytu BioScience and Neos Therapeutics Announce Definitive Merger Agreement, Creating a Combined $100M Revenue¹ Specialty Pharmaceutical Company
December 10, 2020
 · 
13 min read
Load More